The Behavioral Consequence of Phenylketonuria in Mice Depends on the Genetic Background-Reference-Cited by-同舟云学术

The Behavioral Consequence of Phenylketonuria in Mice Depends on the Genetic Background

Published:2016-12-20 Issue: Volume:10 Page:
ISSN:1662-5153
Container-title:Frontiers in Behavioral Neuroscience
language:
Short-container-title:Front. Behav. Neurosci.

Author:

Bruinenberg Vibeke M.,van der Goot Els,van Vliet Danique,de Groot Martijn J.,Mazzola Priscila N.,Heiner-Fokkema M. Rebecca,van Faassen Martijn,van Spronsen Francjan J.,van der Zee Eddy A.

Publisher

Frontiers Media SA

Subject

Behavioral Neuroscience,Cognitive Neuroscience,Neuropsychology and Physiological Psychology

Reference42 articles.

1. Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human disease;Alam;Bone,2017

2. 5-Hydroxytryptophan during critical postnatal period improves cognitive performances and promotes dendritic spine maturation in genetic mouse model of phenylketonuria;Andolina;Int. J. Neuropsychopharmacol.,2011

3. The novel object recognition memory: neurobiology, test procedure, and its modifications;Antunes;Cogn. Process.,2012

4. Measuring normal and pathological anxiety-like behaviour in mice: a review;Belzung;Behav. Brain Res.,2001

5. Phenylketonuria;Blau;Lancet,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperactive GluN2B impairs neuroplasticity and cognition in phenylketonuria;2024-06-06

2. Targeting phenylalanine assemblies as a prospective disease-modifying therapy for phenylketonuria;Biophysical Chemistry;2024-05

3. High phenylalanine concentrations induce demyelination and microglial activation in mouse cerebellar organotypic slices;Frontiers in Neuroscience;2022-09-29

4. Modeling the cognitive effects of diet discontinuation in adults with phenylketonuria (PKU) using pegvaliase therapy in PAH-deficient mice;Molecular Genetics and Metabolism;2022-05

5. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model;PLOS ONE;2022-01-11